[1]
“NETWORK PHARMACOLOGY STUDY ON THE MECHANISM OF DIABETIC NEUROPATHY TREATMENT USING MANGIFERIN”, JMM-NIMM, vol. 27, no. 1, pp. pp. 38 – 44, Aug. 2026, doi: 10.63240/jmm-nimm.2022.1.394.